GENE ONLINE|News &
Opinion
Blog

China
China BeiGene
BeiGene Granted NMPA Approval to Treat World’s Most Prevalent Esophageal Cancer
2022-04-20
China Eye Disease
Backed by RTW, LENZ Therapeutics Inks $110 Vision Loss Pact with China’s JIXING
2022-04-14
China Takeda Pharmaceutical
Shanghai’s Hasten Seals $322 Million Acquisition of Takeda Drugs
2022-04-06
COVID-19 COVID-19 Treatment
Kintor Pharma’s Proxalutamide Demonstrated Reduction in Hospitalization/Mortality for Patients with Mild to Moderate COVID-19 in Phase III MRCT Study
2022-04-05
Deals Vaccine
Bavarian Nordic Establishes Asia Link for Its RSV Vaccines
2022-03-24
China
HitGen Announces Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
2022-03-17
China Cancer
China’s InxMed Raises $50 Million to Inhibit Cancer-Resisting FAKs
2022-03-07
China Cancer
Helsinn Group Gains Marketing Rights to BridgeBio’s Truseltiq in the US
2022-03-04
China Antibody
Sanofi Bets $2.5 billion on Adagene to Make Antibodies Safer
2022-03-03
China Cholesterol
Innovent’s PCSK-9 Antibody Meets Primary Endpoints in Two Phase 3 Studies
2022-02-18
China Gene Editing
China Pushes for Faster Approval for Gene-Edited Crops
2022-02-15
China COVID-19
China Gives Conditional Approval to Pfizer’s Covid-19 Oral Antiviral
2022-02-14
China Autoimmune
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
China Cell Therapy
EdiGene Digs Into Cell Therapies with Arbor and Neukio Partnerships
2022-02-10
China Rare Disease
China’s CANbridge Reports Positive Phase 1 Data of Contender to AstraZeneca’s Complement Inhibitor
2022-02-08
1 2 3 4 5 … 8
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top